Kwan Man

20PUBLICATIONS
62CO-AUTHORS
Predictive and prognostic markersHaematologyMolecular targetsNanomaterialsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 04, 2026
Patient-derived organotypic tumor spheroids as a functional platform for predicting immunotherapeutic responses and guiding precision treatment for hepatocellular carcinoma.

|Feb 19, 2026
CCL11 promotes hepatocellular carcinoma recurrence after surgery by potentiating immunosuppressive CCR5 + CD206 + M2-like macrophages and promoting tumor invasiveness.

Jiaqi Wang, Oscar Wai-Ho Yeung, Wenqi Qiu

|Mar 22, 2025
CXCR3-mediated natural killer cell infiltration exacerbates white matter injury after intracerebral haemorrhage.

Anson C K Ng, Cuiting Zhang, Tsz Lung Lam

|Dec 12, 2024
Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy.

Yating Zhang, Mingxu Xie, Jun Wen

|Sep 17, 2024
Precise In Situ Delivery of a Photo-Enhanceable Inflammasome-Activating Nanovaccine Activates Anticancer Immunity.

Yang Zhou, Li Pang, Tao Ding

|Dec 09, 2023
Enhancing the efficacy of vaccinia-based oncolytic virotherapy by inhibiting CXCR2-mediated MDSC trafficking.

Zhiwu Tan, Mei Sum Chiu, Ming Yue

Pageof 4

Frequent Collaborators

3 joint publications

Stephanie Ma

3 joint publications

Zhiwei Chen

2 joint publications

Tin-Lok Wong

2 joint publications

Terence K Lee